PortfoliosLab logoPortfoliosLab logo
SHW vs. RVMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SHW vs. RVMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Sherwin-Williams Company (SHW) and Revolution Medicines, Inc. (RVMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SHW achieves a -0.69% return, which is significantly lower than RVMD's 100.95% return.


SHW

1D
0.93%
1M
6.99%
YTD
-0.69%
6M
-2.03%
1Y
-3.77%
3Y*
9.88%
5Y*
4.52%
10Y*
13.83%

RVMD

1D
4.02%
1M
9.89%
YTD
100.95%
6M
102.61%
1Y
294.33%
3Y*
86.64%
5Y*
35.73%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SHW vs. RVMD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SHW
The Sherwin-Williams Company
-0.69%-3.83%9.90%32.73%-31.96%44.90%27.80%
RVMD
Revolution Medicines, Inc.
100.95%82.10%52.51%20.40%-5.36%-36.42%40.34%

Correlation

The correlation between SHW and RVMD is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Feb 13, 2020

0.22

Fundamentals

Market Cap

SHW:

$79.45B

RVMD:

$31.71B

EPS

SHW:

$10.42

RVMD:

-$7.17

PB Ratio

SHW:

17.93

RVMD:

21.14

Total Revenue (TTM)

SHW:

$23.94B

RVMD:

$0.00

Gross Profit (TTM)

SHW:

$11.76B

RVMD:

-$4.70M

EBITDA (TTM)

SHW:

$4.29B

RVMD:

-$1.34B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SHW vs. RVMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHW
SHW Risk / Return Rank: 3434
Overall Rank
SHW Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
SHW Sortino Ratio Rank: 3030
Sortino Ratio Rank
SHW Omega Ratio Rank: 3030
Omega Ratio Rank
SHW Calmar Ratio Rank: 3636
Calmar Ratio Rank
SHW Martin Ratio Rank: 3737
Martin Ratio Rank

RVMD
RVMD Risk / Return Rank: 9898
Overall Rank
RVMD Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
RVMD Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMD Omega Ratio Rank: 9898
Omega Ratio Rank
RVMD Calmar Ratio Rank: 9898
Calmar Ratio Rank
RVMD Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SHW vs. RVMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Sherwin-Williams Company (SHW) and Revolution Medicines, Inc. (RVMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SHWRVMDDifference
Sharpe ratioReturn per unit of total volatility

-4.57

Sortino ratioReturn per unit of downside risk

-5.64

Omega ratioGain probability vs. loss probability

0.99

1.78

-0.79

Calmar ratioReturn relative to maximum drawdown

-0.18

11.88

-12.06

Martin ratioReturn relative to average drawdown

-0.37

28.48

-28.85

SHW vs. RVMD - Sharpe Ratio Comparison

The current SHW Sharpe Ratio is -0.15, which is lower than the RVMD Sharpe Ratio of 4.41. The chart below compares the historical Sharpe Ratios of SHW and RVMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SHW vs. RVMD - Drawdown Comparison

The maximum SHW drawdown since its inception was -52.02%, smaller than the maximum RVMD drawdown of -73.29%. Use the drawdown chart below to compare losses from any high point for SHW and RVMD.


Loading charts...

Drawdown Indicators


SHWRVMDDifference

Max Drawdown

Largest peak-to-trough decline

-52.02%

-73.29%

+21.27%

Max Drawdown (1Y)

Largest decline over 1 year

-21.36%

-24.95%

+3.59%

Max Drawdown (3Y)

Largest decline over 3 years

-25.69%

-48.63%

+22.94%

Max Drawdown (5Y)

Largest decline over 5 years

-42.46%

-57.95%

+15.49%

Max Drawdown (10Y)

Largest decline over 10 years

-42.46%

Current Drawdown

Current decline from peak

-18.78%

-2.21%

-16.57%

Average Drawdown

Average peak-to-trough decline

-11.63%

-35.66%

+24.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.26%

10.57%

-0.31%

Volatility

SHW vs. RVMD - Volatility Comparison

The current volatility for The Sherwin-Williams Company (SHW) is 9.00%, while Revolution Medicines, Inc. (RVMD) has a volatility of 13.97%. This indicates that SHW experiences smaller price fluctuations and is considered to be less risky than RVMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SHWRVMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.00%

13.97%

-4.97%

Volatility (6M)

Calculated over the trailing 6-month period

19.26%

55.20%

-35.94%

Volatility (1Y)

Calculated over the trailing 1-year period

24.88%

67.30%

-42.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.27%

62.58%

-36.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.60%

65.75%

-39.15%

Dividends

SHW vs. RVMD - Dividend Comparison

SHW's dividend yield for the trailing twelve months is around 0.99%, while RVMD has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
RVMD
Revolution Medicines, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SHW
The Sherwin-Williams Company
0.99%0.98%0.84%0.78%1.01%0.62%0.73%0.77%0.87%0.83%1.25%1.03%

Financials

SHW vs. RVMD - Financials Comparison

This section allows you to compare key financial metrics between The Sherwin-Williams Company and Revolution Medicines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B20222023202420252026
5.67B
0
(SHW) Total Revenue
(RVMD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SHW and RVMD have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RVMD has higher volatility (13.97%) compared to SHW (9.00%). In terms of maximum drawdown, SHW dropped -52.02% vs RVMD's -73.29%.

RVMD currently has the higher Sharpe Ratio (4.41 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SHW and RVMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer